Medically reviewed by Dr Sin Yong · Last reviewed · Doctor-performed, never delegated · Jump to questions
Dr Sin Yong · MBBS (NUS) · MRCS (Edin) · MSc Aesthetic Medicine with Distinction (Queen Mary, London) · MSc Practical Dermatology (Cardiff) · Global Key Opinion Leader
Regenera Activa is an autologous micrografting hair loss treatment in Singapore, used for both male and female pattern loss. Tissue is taken from the patient's own DHT-protected scalp, processed into a micrograft suspension, and returned to the thinning area — all within a single session.
Regenera Activa is an autologous micrografting treatment for male and female pattern hair loss in Singapore. Small samples of the patient's own scalp from the hormone-resistant zone are processed into a micrograft suspension and returned to thinning areas at the same visit. Staging comes first, because it works on miniaturising follicles, not ones already lost.
Androgenetic alopecia (pattern hair loss) is treated in layers: medical therapy (minoxidil, finasteride or dutasteride where appropriate) to slow loss, then regenerative options to support the follicles that remain. Micrografting is one of those options: micrografts from the patient’s own scalp are processed and injected into thinning areas in a single session. It is for thinning, not bald, scalp; Dr Sin Yong confirms the diagnosis with trichoscopy first, because hair loss that is not pattern loss needs a different plan.
For diagnosis and the other treatments, see the hair guides on this site.
The cost of micrografting, and what sets the hair transplant cost in Singapore, are set out on the cost factors page.
It is sometimes marketed as a stem cell hair treatment, a description examined below.
Before any discussion of treatment, the pattern and stage of hair loss need establishing. This is not administrative. Androgenetic alopecia is progressive, and follicles pass through miniaturisation before they are lost altogether. A follicle that is miniaturising can still respond. One that has gone cannot.

Staging tells you which of those you are dealing with, and therefore what any hair loss treatment can realistically be expected to do. This applies equally to male hair loss treatment and to female hair loss treatment in Singapore. The Norwood and Ludwig scales used for staging are explained on the androgenetic alopecia page.
“Staging is not paperwork. It tells you how many follicles are still there to work with, and that decides what is realistic.”
Dr Sin YongOn assessing hair loss
The procedure rests on a straightforward observation: not all scalp follicles are equally affected by DHT. Those at the back and sides — the occipital and retro-auricular scalp — are comparatively protected, and that region is well vascularised. It is the same anatomical fact that makes hair transplantation possible.

Three 2.5 mm punch biopsies are taken from that protected area under local anaesthetic — a scalp treatment for hair loss that begins with the patient’s own tissue. The tissue is then mechanically disaggregated and filtered using Rigenera® technology, producing micrografts of approximately 80 microns.
What results is a suspension containing progenitor cells, signalling factors and extracellular matrix — all derived from the patient's own tissue. This is injected into the thinning regions of the scalp, where it acts on the follicular environment with the aim of supporting hair regrowth from follicles still present.
Donor and recipient are the same person, within one session. Nothing foreign is introduced.
This is a single-visit procedure once the assessment is done: the donor tissue is taken, processed and injected in the same session, and nothing foreign is introduced. Donor and recipient are the same person. The six steps below are what the visit involves at Dr Sin Yong's practice on Orchard Road, from staging to review.

Two points of accuracy sit behind those steps. It is not a hair transplant: no follicles are moved, and the suspension is intended to act on follicles that are still present in the thinning area. Nor is it accurately a stem cell treatment, because progenitor cells are more restricted in what they can become. That is why staging comes first. A miniaturising follicle can respond; a follicle that has closed cannot, which is the point Dr Sin Yong makes on the androgenetic alopecia page. Where staging shows long-established loss with few surviving follicles, micrografting is not advised.
Micrografting is one of three routes, and a considered plan usually draws on more than one. Oral and topical therapy act on the hormonal driver and on follicular perfusion, as set out on anti-hair-loss medications. Laser therapy is directed at scalp perfusion, and the micrografts act on the follicular environment. In women, the Ludwig stage and blood tests for iron and thyroid come first, which is covered on female hair thinning. The glossary entry on micrografting explains the terminology, and what the name “stem cell hair treatment” covers is set out on the hair regrowth treatment page.
“A miniaturising follicle can respond. A follicle that has closed cannot. Everything else follows from that.”
Dr Sin YongOn why staging comes first
Micrografting is one layer of a hair loss plan, not a replacement for the others. This table sets out what each option does and where it fits, so the question at consultation is which combination suits your stage.

| Option | What it does | Tends to suit | What it does not do |
|---|---|---|---|
| Medication | Slows the hormonal miniaturisation behind pattern hair loss | Most stages, as the foundation of the plan | Restore follicles that have already gone |
| Laser therapy | Supports the scalp environment around the follicle | Early to moderate thinning, alongside medication | Replace medical treatment |
| Regenera Activa | Returns a micrograft suspension from your own scalp to thinning areas | Thinning with miniaturising follicles still present | Move follicles, or regrow hair in bald, shiny skin |
| PRP | Injects concentrated platelets from your own blood into the scalp | Selected cases, as studied in the literature | Act on the hormonal driver |
| Hair transplant | Relocates intact follicular units to thinning or bald areas | Stable loss with an adequate donor area | Stop loss continuing in untreated areas |
The order follows the stage. Medication protects what is left, procedures act on areas that are thinning, and a transplant moves hair where it has gone. Because androgenetic alopecia is progressive, most plans combine more than one layer and are reviewed with record photographs. For how laser therapy is used, see hair loss laser treatment; for transplant assessment, see hair transplant in Singapore.
Dr Sin Yong stages the loss and excludes other causes before suggesting any procedure, and writes down which layers he recommends and why.
Role of Autologous Micrografting Technology through the Rigenera® System in the Treatment of Androgenetic Alopecia. Skin Appendage Disorders, Karger. karger.com
The published studies of autologous micrografts are small and mostly observational. In a 2025 multicentre, evaluator-blinded study, 60 people with mild to moderate pattern hair loss, 40 men and 20 women, were treated and followed for one year with standardised hair counts. The authors concluded that micrografts may be a safe and viable alternative for mild and moderate hair loss.

The study had no randomised comparison with medication. A network meta-analysis of non-surgical hair loss treatments rated the overall quality of evidence in this field as low. Micrografting is therefore presented here as an option with early supporting evidence, and it is compared with medication, which has the larger evidence base, in the section above.
People with advanced loss and few follicles remaining, or who expect the density of a hair transplant, tend to respond poorly, and a transplant assessment suits them better.

Mild soreness, small donor-site wounds, localised swelling and tenderness or tightness in the treated scalp are expected after the procedure. Less commonly, there can be bleeding, infection at a donor or injection site, a small visible mark, or altered sensation. Local anaesthetic can occasionally cause a reaction. Any hair loss treatment is influenced by stage, cause, age, medical history and adherence to the plan, and androgenetic alopecia is progressive, so no outcome can be promised and no single approach halts it outright.

The fee depends on the extent of the area treated, since a localised vertex is planned differently to diffuse loss across the crown. It also depends on the stage identified at assessment, the consumables used, and whether micrografting is used alone or combined with medical or laser management. A written quote is given at consultation after examination, and the consultation decides whether treatment is advised at all.
| Treatment | Price |
|---|---|
| Regenera Activa, per session | From $3,000 |
Prices are nett. Each figure is a starting price; the fee for your plan depends on the area treated and what the assessment finds, and is confirmed in writing before any treatment.

How quotes work at this practice: how we quote.
Leave your name, mobile number and email and the clinic will contact you directly.
Hair Loss Is Silent Long Before It's Visible
Watch on YouTube: Receding Hairline: Hair Loss Is Silent Before It's Visible
Hair loss is silent before it's visible. Many men wait until the mirror is undeniable. Density drops a long way before it's obvious in a photograph. The window that matters is the one where the follicle is still alive, and it closes quietly. If your parting is widening, that's the signal. Don't wait for the photo that makes it obvious to everyone else.
Transcript of Dr Sin Yong's video, lightly edited for reading.
A brand page or an overseas clinic cannot tell you how Regenera Activa is delivered here. These are the points worth checking with any clinic in Singapore.
Consultations with Dr Sin Yong are at 9 Scotts Road, Pacific Plaza #12-01, Singapore 228210.
Regenera Activa is an autologous micrografting treatment for hair loss. Three small 2.5 mm punch biopsies are taken from the occipital scalp, mechanically disaggregated and filtered to produce a suspension of progenitor cells, signalling factors and extracellular matrix. This is then injected into the thinning areas. Because the tissue comes from the patient, donor and recipient are the same person within one session.
No. A hair transplant moves intact follicular units from a donor area to a recipient area, and the transplanted hairs are the result. Regenera Activa does not move follicles. It introduces a cellular suspension intended to act on follicles already present in the thinning area. The two are different procedures answering different situations, and in some cases they are used alongside one another.
Female pattern hair loss is one of the presentations micrografting is used for. Female pattern loss usually presents as diffuse thinning over the crown with the frontal hairline preserved, staged on the Ludwig scale, and behaves differently from male pattern loss. Suitability is decided by assessment rather than by pattern alone.
They are related but not identical, and the distinction is worth making because the treatment is often described loosely as a stem cell procedure. Progenitor cells are more restricted in what they can become than stem cells are. The suspension produced by micrografting contains progenitor cells alongside signalling factors and extracellular matrix. Describing it as a stem cell transplant overstates what the procedure does.
Not necessarily. Topical therapy acts on follicular perfusion and oral therapy blocks the conversion of testosterone to DHT, addressing the hormonal driver. Micrografting acts through a third route. Because androgenetic alopecia is progressive, plans commonly combine approaches rather than relying on one, and what is appropriate is decided at consultation.
Local anaesthetic is used at both the donor and recipient sites. Most patients describe pressure rather than pain. Tolerance varies between individuals, and comfort is discussed and managed during the session.
Suitability is assessed in person. Scarring alopecia, active scalp infection or inflammation, certain autoimmune and medical conditions, bleeding disorders, and pregnancy are among the things considered. Very pronounced hair loss with few remaining follicles is also unlikely to benefit, and saying so is part of an honest assessment.
It is worth considering for pattern hair loss at a stage where miniaturising follicles remain, in someone who wants a procedure using their own tissue and accepts that it works alongside other therapy. It is a poor fit where follicles are already lost, where the cause is not androgenetic, or where the expectation is the density a hair transplant gives.
How long any effect lasts depends on the stage and cause of hair loss, your age, medical history, how well the plan is followed, and whether other therapy continues. Androgenetic alopecia is progressive, so no duration can be promised. Review timing, and whether repeat treatment is sensible, are decided with Dr Sin Yong at consultation.
It works only on follicles that are still present, does not halt progressive hair loss outright, and is not a hair transplant. Donor-site soreness, small wounds and tenderness are expected; bleeding, infection or anaesthetic reactions are uncommon. Response varies, repeat treatment may be considered, and it usually sits alongside medical or laser management rather than replacing it.
Different stages. PRP and Regenera Activa support follicles that are miniaturising but present; a transplant moves follicles into areas that have none. Dr Sin Yong maps the scalp with trichoscopy and says which stage you are at. See hair loss treatment.
Question not answered here? Ask on WhatsApp, use the enquiry form, or browse 100 questions patients ask.
1. Lolli F, Pallotti F, Rossi A, et al. Androgenetic alopecia: a review. Endocrine 2017;57(1):9-17. PubMed
2. Gupta AK, Bamimore MA, Foley KA. Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality. J Dermatolog Treat 2022;33(1):62-72. PubMed
Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss (Gentile P, Scioli MG, Bielli A, et al.). Stem Cell Investigation, 2017. pubmed.ncbi.nlm.nih.gov
Progenitor-cell-enriched micrografts as a novel option for the management of androgenetic alopecia (Ruiz RG, Rosell JMC, Ceccarelli G, et al.). Journal of Cellular Physiology, 2020. pubmed.ncbi.nlm.nih.gov
Gentile P, Garcovich S, Perego F, Arsiwala N, Yavuz MF, Pessei V, et al. Autologous Micrografts Containing Nanovesicles, Exosomes, and Follicle Stem Cells in Androgenetic Alopecia: In Vitro and In Vivo Analysis Through a Multicentric, Observational, Evaluator-Blinded Study. Aesthetic Plastic Surgery, 2025. doi.org
Gupta AK, Mays RR, Dotzert MS, Versteeg SG, Shear NH, Piguet V. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. Journal of the European Academy of Dermatology and Venereology, 2018. doi.org
Medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last reviewed 8 November 2026 · Editorial policy
Consultations by appointment at 9 Scotts Road, Pacific Plaza #12-01, Singapore 228210.
Replies within clinic hours: Mon–Fri 10am–8pm, Sat 11am–3pm · How consultations work · Prefer not to use WhatsApp? · Treatment finder · Call +65 8023 7170 · Map
WhatsApp +65 8023 7170 →